UMass Chan Medical School Hematology and Medical Oncology

Topics

• Lymphoma Diagnosis and Treatment 88
• Multiple Myeloma Research and Treatments 88
• Hematopoietic Stem Cell Transplantation 84
• Acute Myeloid Leukemia Research 82
• CAR-T cell therapy research 42
• Chronic Lymphocytic Leukemia Research 39
• Glioma Diagnosis and Treatment 25
• Mesenchymal stem cell research 22
• COVID-19 and healthcare impacts 16
• HIV Research and Treatment 16
• Chronic Myeloid Leukemia Treatments 14
• Cancer Immunotherapy and Biomarkers 13

Most cited

1. Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.

   The New England journal of medicine · 2022 · 422 citations · Eva Medvedova

2. Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.

   The New England journal of medicine · 2025 · 84 citations · Eva Medvedova

3. Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.

   The New England journal of medicine · 2023 · 204 citations · Deepa Jagadeesh

4. Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab.

   The New England journal of medicine · 2026 · 33 citations · Eva Medvedova

5. Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers.

   ESMO open · 2022 · 289 citations · Pallvi Popli

6. Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 224 citations · Eva Medvedova